Skip to main content
Erschienen in: Current Cardiovascular Risk Reports 1/2010

01.01.2010

Metagenomics, Lipoproteins, and Cardiovascular Risk

verfasst von: Erik Eckhardt

Erschienen in: Current Cardiovascular Risk Reports | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Triglyceride-rich lipoproteins—very low-density lipoproteins (VLDL) and chylomicrons—are considered atherogenic. The postprandial state, during which plasma levels of these lipoproteins are increased, is characterized by an inflammatory response that also involves endothelia. Free fatty acids released from chylomicrons and VLDL near the endothelium may be responsible for this. However, recent studies on mice and human subjects have revealed that intestinal absorption of dietary fat promotes absorption of bacterial lipopolysaccharides (LPS), which are atherogenic. Absorbed LPS is transported on chylomicrons, which suggests that LPS could contribute to postprandial inflammation. Recent work suggests that the intestinal microflora may influence atherosclerosis by affecting energy harvest from the diet. The novel link between intestinal absorption of fat and of LPS suggests that the microflora could also affect atherosclerosis by providing proinflammatory material to the bloodstream. Unraveling the chylomicron-associated LPS absorption mechanism and identification of micro-organisms providing the LPS may be beneficial for the prevention of atherosclerosis.
Literatur
1.
Zurück zum Zitat Wiedermann CJ, Kiechl S, Dunzendorfer S, et al.: Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck study. J Am Coll Cardiol 1999, 34:1975–1981.CrossRefPubMed Wiedermann CJ, Kiechl S, Dunzendorfer S, et al.: Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck study. J Am Coll Cardiol 1999, 34:1975–1981.CrossRefPubMed
2.
Zurück zum Zitat Duffy D, Rader DJ: Update on strategies to increase HDL quantity and function. Nat Rev Cardiol 2009, 6:455–463.CrossRefPubMed Duffy D, Rader DJ: Update on strategies to increase HDL quantity and function. Nat Rev Cardiol 2009, 6:455–463.CrossRefPubMed
3.
Zurück zum Zitat Florentin M, Liberopoulos EN, Wierzbicki AS, Mikhailidis DP: Multiple actions of high-density lipoprotein. Curr Opin Cardiol 2008, 23:370–378.CrossRefPubMed Florentin M, Liberopoulos EN, Wierzbicki AS, Mikhailidis DP: Multiple actions of high-density lipoprotein. Curr Opin Cardiol 2008, 23:370–378.CrossRefPubMed
4.
Zurück zum Zitat Tabas I, Williams KJ, Boren J: Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 2007, 116:1832–1844.CrossRefPubMed Tabas I, Williams KJ, Boren J: Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 2007, 116:1832–1844.CrossRefPubMed
5.
Zurück zum Zitat Steinberg D, Parthasarathy S, Carew TE, et al.: Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989, 320:915–924.PubMedCrossRef Steinberg D, Parthasarathy S, Carew TE, et al.: Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989, 320:915–924.PubMedCrossRef
6.
Zurück zum Zitat Burdge GC, Calder PC: Plasma cytokine response during the postprandial period: a potential causal process in vascular disease? Br J Nutr 2005, 93:3–9.CrossRefPubMed Burdge GC, Calder PC: Plasma cytokine response during the postprandial period: a potential causal process in vascular disease? Br J Nutr 2005, 93:3–9.CrossRefPubMed
7.
Zurück zum Zitat van Oostrom AJ, Sijmonsma TP, Verseyden C, et al.: Postprandial recruitment of neutrophils may contribute to endothelial dysfunction. J Lipid Res 2003, 44:576–583.CrossRefPubMed van Oostrom AJ, Sijmonsma TP, Verseyden C, et al.: Postprandial recruitment of neutrophils may contribute to endothelial dysfunction. J Lipid Res 2003, 44:576–583.CrossRefPubMed
8.
Zurück zum Zitat Margioris AN: Fatty acids and postprandial inflammation. Curr Opin Clin Nutr Metab Care 2009, 12:129–137.CrossRefPubMed Margioris AN: Fatty acids and postprandial inflammation. Curr Opin Clin Nutr Metab Care 2009, 12:129–137.CrossRefPubMed
9.
Zurück zum Zitat •• Beigneux AP, Davies BS, Gin P, et al.: Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab 2007, 5:279–291. This article identifies a novel factor within the endothelium that promotes lipolytic clearance of chylomicrons. •• Beigneux AP, Davies BS, Gin P, et al.: Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab 2007, 5:279–291. This article identifies a novel factor within the endothelium that promotes lipolytic clearance of chylomicrons.
10.
Zurück zum Zitat Higgins LJ, Rutledge JC: Inflammation associated with the postprandial lipolysis of triglyceride-rich lipoproteins by lipoprotein lipase. Curr Atheroscler Rep 2009, 11:199–205.CrossRefPubMed Higgins LJ, Rutledge JC: Inflammation associated with the postprandial lipolysis of triglyceride-rich lipoproteins by lipoprotein lipase. Curr Atheroscler Rep 2009, 11:199–205.CrossRefPubMed
11.
Zurück zum Zitat Chung BH, Hennig B, Cho BH, Darnell BE: Effect of the fat composition of a single meal on the composition and cytotoxic potencies of lipolytically-releasable free fatty acids in postprandial plasma Atherosclerosis 1998, 141:321–332. Chung BH, Hennig B, Cho BH, Darnell BE: Effect of the fat composition of a single meal on the composition and cytotoxic potencies of lipolytically-releasable free fatty acids in postprandial plasma Atherosclerosis 1998, 141:321–332.
12.
Zurück zum Zitat Shi H, Kokoeva MV, Inouye K, et al.: TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006, 116:3015–3025.CrossRefPubMed Shi H, Kokoeva MV, Inouye K, et al.: TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006, 116:3015–3025.CrossRefPubMed
13.
Zurück zum Zitat Suganami T, Tanimoto-Koyama K, Nishida J, et al.: Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 2007, 27:84–91.CrossRefPubMed Suganami T, Tanimoto-Koyama K, Nishida J, et al.: Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 2007, 27:84–91.CrossRefPubMed
14.
Zurück zum Zitat Lee JY, Sohn KH, Rhee SH, Hwang D: Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem 2001, 276:16683–16689.CrossRefPubMed Lee JY, Sohn KH, Rhee SH, Hwang D: Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem 2001, 276:16683–16689.CrossRefPubMed
15.
Zurück zum Zitat • Erridge C, Samani NJ: Saturated fatty acids do not directly stimulate Toll-like receptor signaling. Arterioscler Thromb Vasc Biol 2009, 29:1944–1949. This article argues against a direct role of FFAs in the activation of TLR4, suggesting that other factors associated with lipoproteins are involved. • Erridge C, Samani NJ: Saturated fatty acids do not directly stimulate Toll-like receptor signaling. Arterioscler Thromb Vasc Biol 2009, 29:1944–1949. This article argues against a direct role of FFAs in the activation of TLR4, suggesting that other factors associated with lipoproteins are involved.
16.
Zurück zum Zitat Michelsen KS, Wong MH, Shah PK, et al.: Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein Proc Natl Acad Sci USA 2004, 101:10679–10684.CrossRefPubMed Michelsen KS, Wong MH, Shah PK, et al.: Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein Proc Natl Acad Sci USA 2004, 101:10679–10684.CrossRefPubMed
17.
Zurück zum Zitat Kiechl S, Lorenz E, Reindl M, et al.: Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002, 347:185–192.CrossRefPubMed Kiechl S, Lorenz E, Reindl M, et al.: Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002, 347:185–192.CrossRefPubMed
18.
Zurück zum Zitat Ameziane N, Beillat T, Verpillat P, et al.: Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler Thromb Vasc Biol 2003, 23:e61–e64.CrossRefPubMed Ameziane N, Beillat T, Verpillat P, et al.: Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler Thromb Vasc Biol 2003, 23:e61–e64.CrossRefPubMed
19.
20.
Zurück zum Zitat Turnbaugh PJ, Ley RE, Mahowald MA, et al.: An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027–1031.CrossRefPubMed Turnbaugh PJ, Ley RE, Mahowald MA, et al.: An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027–1031.CrossRefPubMed
21.
Zurück zum Zitat Backhed F, Manchester JK, Semenkovich CF, Gordon JI: Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 2007, 104:979–984.CrossRefPubMed Backhed F, Manchester JK, Semenkovich CF, Gordon JI: Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 2007, 104:979–984.CrossRefPubMed
22.
Zurück zum Zitat • Turnbaugh PJ, Hamady M, Yatsunenko T, et al.: A core gut microbiome in obese and lean twins. Nature 2009, 457:480–484. This article reveals considerable interindividual variation in the gut microbiome among humans, yet it argues for the presence of a core microbiome that is associated with obesity. • Turnbaugh PJ, Hamady M, Yatsunenko T, et al.: A core gut microbiome in obese and lean twins. Nature 2009, 457:480–484. This article reveals considerable interindividual variation in the gut microbiome among humans, yet it argues for the presence of a core microbiome that is associated with obesity.
23.
Zurück zum Zitat McGill HC Jr, McMahan CA, Herderick EE, et al.: Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 2002, 105:2712–2718.CrossRefPubMed McGill HC Jr, McMahan CA, Herderick EE, et al.: Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 2002, 105:2712–2718.CrossRefPubMed
24.
Zurück zum Zitat • Queenan K, Stewart M, Smith K, et al.: Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr J 2007, 6:6. The authors performed human studies to show that butyrate mediates LDL-lowering effects of high-fiber diets. • Queenan K, Stewart M, Smith K, et al.: Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr J 2007, 6:6. The authors performed human studies to show that butyrate mediates LDL-lowering effects of high-fiber diets.
25.
Zurück zum Zitat Wachtershauser A, Loitsch SM, Stein J: PPAR-gamma is selectively upregulated in Caco-2 cells by butyrate. Biochem Biophys Res Commun 2000, 272:380–385.CrossRefPubMed Wachtershauser A, Loitsch SM, Stein J: PPAR-gamma is selectively upregulated in Caco-2 cells by butyrate. Biochem Biophys Res Commun 2000, 272:380–385.CrossRefPubMed
26.
Zurück zum Zitat Neutra MR, Pringault E, Kraehenbuhl JP: Antigen sampling across epithelial barriers and induction of mucosal immune responses. Annu Rev Immunol 1996, 14:275–300.CrossRefPubMed Neutra MR, Pringault E, Kraehenbuhl JP: Antigen sampling across epithelial barriers and induction of mucosal immune responses. Annu Rev Immunol 1996, 14:275–300.CrossRefPubMed
27.
Zurück zum Zitat Rescigno M, Urbano M, Valzasina B, et al.: Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001, 2:361–367.CrossRefPubMed Rescigno M, Urbano M, Valzasina B, et al.: Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001, 2:361–367.CrossRefPubMed
28.
Zurück zum Zitat Macpherson AJ, Uhr T: Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004, 303:1662–1665.CrossRefPubMed Macpherson AJ, Uhr T: Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004, 303:1662–1665.CrossRefPubMed
29.
Zurück zum Zitat Nadhazi Z, Takats A, Offenmuller K, Bertok L: Plasma endotoxin level of healthy donors. Acta Microbiol Immunol Hung 2002, 49:151–157.CrossRefPubMed Nadhazi Z, Takats A, Offenmuller K, Bertok L: Plasma endotoxin level of healthy donors. Acta Microbiol Immunol Hung 2002, 49:151–157.CrossRefPubMed
30.
Zurück zum Zitat Ravin HA, Rowley D, Jenkins C, Fine J: On the absorption of bacterial endotoxin from the gastro-intestinal tract of the normal and shocked animal. J Exp Med 1960, 112:783–792.CrossRefPubMed Ravin HA, Rowley D, Jenkins C, Fine J: On the absorption of bacterial endotoxin from the gastro-intestinal tract of the normal and shocked animal. J Exp Med 1960, 112:783–792.CrossRefPubMed
31.
Zurück zum Zitat •• Cani PD, Amar J, Iglesias MA, et al.: Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761–1772. Mice on high-fat diets absorb LPS from the gut. Infusion of similar levels of LPS in mice on low-fat diets led to a similar phenotype as mice on high-fat diets. Thus, gut LPS contributes to metabolic disorders linked with high-fat dieting. •• Cani PD, Amar J, Iglesias MA, et al.: Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761–1772. Mice on high-fat diets absorb LPS from the gut. Infusion of similar levels of LPS in mice on low-fat diets led to a similar phenotype as mice on high-fat diets. Thus, gut LPS contributes to metabolic disorders linked with high-fat dieting.
32.
Zurück zum Zitat • Erridge C, Attina T, Spickett CM, Webb DJ: A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 2007, 86:1286–1292. The authors show, using human subjects, that postprandial lipid levels correlate with LPS levels, suggesting a link between LPS absorption and fat absorption. • Erridge C, Attina T, Spickett CM, Webb DJ: A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 2007, 86:1286–1292. The authors show, using human subjects, that postprandial lipid levels correlate with LPS levels, suggesting a link between LPS absorption and fat absorption.
33.
Zurück zum Zitat • Ghoshal S, Witta J, Zhong J, et al.: Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 2009, 50:90–97. The authors show that chylomicron formation is required for the promotion of LPS absorption by dietary fat. • Ghoshal S, Witta J, Zhong J, et al.: Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 2009, 50:90–97. The authors show that chylomicron formation is required for the promotion of LPS absorption by dietary fat.
34.
Zurück zum Zitat Kvietys PR, Specian RD, Grisham MB, Tso P: Jejunal mucosal injury and restitution: role of hydrolytic products of food digestion. Am J Physiol 1991, 261(3 Pt 1):G384–G391.PubMed Kvietys PR, Specian RD, Grisham MB, Tso P: Jejunal mucosal injury and restitution: role of hydrolytic products of food digestion. Am J Physiol 1991, 261(3 Pt 1):G384–G391.PubMed
35.
Zurück zum Zitat Harris HW, Grunfeld C, Feingold KR, et al.: Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest 1993, 91:1028–1034.CrossRefPubMed Harris HW, Grunfeld C, Feingold KR, et al.: Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest 1993, 91:1028–1034.CrossRefPubMed
36.
Zurück zum Zitat Vreugdenhil AC, Snoek AM, Greve JM, Buurman WA: Lipopolysaccharide-binding protein is vectorially secreted and transported by cultured intestinal epithelial cells and is present in the intestinal mucus of mice. J Immunol 2000, 165:4561–4566.PubMed Vreugdenhil AC, Snoek AM, Greve JM, Buurman WA: Lipopolysaccharide-binding protein is vectorially secreted and transported by cultured intestinal epithelial cells and is present in the intestinal mucus of mice. J Immunol 2000, 165:4561–4566.PubMed
37.
Zurück zum Zitat Neal MD, Leaphart C, Levy R, et al.: Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J Immunol 2006, 176:3070–3079.PubMed Neal MD, Leaphart C, Levy R, et al.: Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J Immunol 2006, 176:3070–3079.PubMed
38.
Zurück zum Zitat Hornef MW, Frisan T, Vandewalle A, et al.: Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J Exp Med 2002, 195:559–570.CrossRefPubMed Hornef MW, Frisan T, Vandewalle A, et al.: Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J Exp Med 2002, 195:559–570.CrossRefPubMed
39.
Zurück zum Zitat Luchoomun J, Hussain MM: Assembly and secretion of chylomicrons by differentiated Caco-2 cells. Nascent triglycerides and preformed phospholipids are preferentially used for lipoprotein assembly. J Biol Chem 1999, 274:19565–19572. Luchoomun J, Hussain MM: Assembly and secretion of chylomicrons by differentiated Caco-2 cells. Nascent triglycerides and preformed phospholipids are preferentially used for lipoprotein assembly. J Biol Chem 1999, 274:19565–19572.
40.
Zurück zum Zitat Read TE, Harris HW, Grunfeld C, et al.: The protective effect of serum lipoproteins against bacterial lipopolysaccharide. Eur Heart J 1993, 14(Suppl K):125–129. Read TE, Harris HW, Grunfeld C, et al.: The protective effect of serum lipoproteins against bacterial lipopolysaccharide. Eur Heart J 1993, 14(Suppl K):125–129.
41.
Zurück zum Zitat Kasravi B, Lee DH, Lee JW, et al.: Chylomicron-bound LPS selectively inhibits the hepatocellular response to proinflammatory cytokines. J Surg Res 2008, 146:96–103.CrossRefPubMed Kasravi B, Lee DH, Lee JW, et al.: Chylomicron-bound LPS selectively inhibits the hepatocellular response to proinflammatory cytokines. J Surg Res 2008, 146:96–103.CrossRefPubMed
42.
Zurück zum Zitat Smythies LE, Sellers M, Clements RH, et al.: Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest 2005, 115:66–75.PubMed Smythies LE, Sellers M, Clements RH, et al.: Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest 2005, 115:66–75.PubMed
Metadaten
Titel
Metagenomics, Lipoproteins, and Cardiovascular Risk
verfasst von
Erik Eckhardt
Publikationsdatum
01.01.2010
Verlag
Current Science Inc.
Erschienen in
Current Cardiovascular Risk Reports / Ausgabe 1/2010
Print ISSN: 1932-9520
Elektronische ISSN: 1932-9563
DOI
https://doi.org/10.1007/s12170-009-0067-y

Weitere Artikel der Ausgabe 1/2010

Current Cardiovascular Risk Reports 1/2010 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.